Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics N.V (PRQR) Current Leases: 2021-2024

Historic Current Leases for ProQR Therapeutics N.V (PRQR) over the last 4 years, with Dec 2024 value amounting to $11,826.

  • ProQR Therapeutics N.V's Current Leases fell 7.29% to $11,710 in Q3 2025 from the same period last year, while for Sep 2025 it was $11,710, marking a year-over-year decrease of 7.29%. This contributed to the annual value of $11,826 for FY2024, which is 20.94% down from last year.
  • ProQR Therapeutics N.V's Current Leases amounted to $11,826 in FY2024, which was down 20.94% from $14,958 recorded in FY2023.
  • ProQR Therapeutics N.V's 5-year Current Leases high stood at $1.8 million for FY2021, and its period low was $11,826 during FY2024.
  • In the last 3 years, ProQR Therapeutics N.V's Current Leases had a median value of $14,958 in 2023 and averaged $480,622.
  • Data for ProQR Therapeutics N.V's Current Leases shows a maximum YoY slumped of 98.94% (in 2023) over the last 5 years.
  • Over the past 4 years, ProQR Therapeutics N.V's Current Leases (Yearly) stood at $1.8 million in 2021, then dropped by 22.05% to $1.4 million in 2022, then crashed by 98.94% to $14,958 in 2023, then declined by 20.94% to $11,826 in 2024.